© 2020 MJH Life Sciences and Psychiatric Times. All rights reserved.
Psychopharmacology
Perception of Adverse Drug Interactions
July 14, 2020
When is an adverse drug reaction actually a drug interaction? And vice versa? More in this video.
Cytochrome P450: You've Come a Long Way
June 26, 2020
Two examples described here underscore the importance of understanding the cytochrome P450 (CYP) system
Special Issues for Patients With SUDs Undergoing Surgery
May 18, 2020
This innovative program at Massachusetts General Hospital addresses postoperative pain while preventing relapse in patients a history of opioid use disorder.
Top 12 Mistakes in Perinatal Psychiatry
April 22, 2020
Although they may have been the result of good intentions, these mistakes could adversely impact mother and baby.
The Buzz on Long-Acting Injectable Antipsychotics
March 17, 2020
What are the benefits of using LAI antipsychotics? What are the major obstacles to adherence? Those questions and more in this podcast.
Pharmaceutical Company Makes the FDA’s Naughty List
March 06, 2020
After receiving complaints, the FDA’s Office of Prescription Drug Promotion rebukes the pharmaceutical company for misleading advertising.
Pharmacological Management of Violence and Violent Behavior in Psychiatric Settings
February 28, 2020
Psychotic violence is associated with primary psychotic disorders such as schizophrenia, schizoaffective disorder, and bipolar disorder. While it may be that psychotic violence is the least common type of violence in inpatient environments, it is also the most treatable.
The New Year Brings Good News, Bad News
February 26, 2020
Drug companies are investing more to study psychiatric disorders, and there may be novel treatments in the near future.
The Neuroprotective Effects of Lithium
February 14, 2020
Do you need help persuading patients to try lithium?
Integrating Psychotherapy and Psychopharmacology in the Treatment of Major Depressive Disorder
January 30, 2020
Although multiple interventions exist for major depressive disorder (MDD), only partial response is achieved in many patients and recurrence is common. Combining medication and psychotherapy may enable more effective treatment of MDD.